Metabolic Syndrome, Gamma-Glutamyl Transferase, and Risk of Sudden Cardiac Death.

Metabolic syndrome and ɣ-GTP significantly correlated with an increased SCD risk. SCD was also influenced by temporal changes in the metabolic syndrome status and ɣ-GTP, suggesting that appropriate medical treatment and lifestyle modifications may reduce future SCD risk.